ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Chelsea Therapeutics, Inc. 

3530 Toringdon Way
Suite 200
Charlotte  North Carolina  28277  U.S.A.
Phone: 704-341-1516 Fax: 704-752-1479


SEARCH JOBS








 Company News
Chelsea Therapeutics, Inc. (CHTP) Reports Fourth Quarter And Full-Year 2013 Results 3/12/2014 8:57:40 AM    More...
Chelsea Therapeutics, Inc. (CHTP) Joins National Organization for Rare Disorders In Promoting Awareness For Rare Disease Day 2/28/2014 9:49:55 AM    More...
Chelsea Therapeutics, Inc. (CHTP) Pops As FDA Finally Approves NORTHERA™ 2/19/2014 6:52:04 AM    More...
Nervous Chelsea Therapeutics, Inc. (CHTP) Still Awaiting News From The FDA On NORTHERA™ 2/17/2014 6:43:47 AM    More...
Chelsea Therapeutics, Inc. (CHTP) Names Keith W. Schmidt Chief Commercial Officer 1/30/2014 8:42:25 AM    More...
Chelsea Therapeutics, Inc. (CHTP) Announces Joseph G. Oliveto Named President And Chief Executive Officer, Director 1/27/2014 7:07:45 AM    More...
Chelsea Therapeutics, Inc. (CHTP) Rockets Before Market Opens After Northera Finally Wins FDA Panel Backing 1/15/2014 6:04:37 AM    More...
Chelsea Therapeutics, Inc. (CHTP) Blues: FDA Reviewer Still Finds Problems With Fainting Drug Northera 1/10/2014 7:37:34 AM    More...
Chelsea Therapeutics, Inc. (CHTP) Announces First Patient Dosed In NORTHERA™ (Droxidopa) Study 401 For The Treatment Of Symptomatic NOH 12/9/2013 9:40:07 AM    More...
Chelsea Therapeutics, Inc. (CHTP) Completes Public Offering Of Common Stock 11/18/2013 9:13:30 AM    More...
12345678910...